Health Literacy Innovations Supports Health Literacy Month -- Announces New Sale, Complimentary Licenses to Qualified Applicants
Bethesda, Maryland (PRWEB) October 15, 2014 -- In celebration of October – health literacy month – Health Literacy Innovations, creators of the Health Literacy Advisor (HLA), an interactive health literacy software (in English and Spanish), today announces two new events: a major sale and a new study that offers qualified applicants a free one-month HLA license.
Starting October 1, all copies of the HLA will be discounted by 20% - the HLA English priced at $399 and the HLA English/Spanish $498. Additional discounts of 10, 15, and 20% are offered for 2, 3, and/or 4-year licenses.
HLI also launches a new Evaluation Survey, a brief survey that offers qualified applicants a free-one month evaluation for testing the HLA. To join the study, please contact marketing(at)healthliteracyinnovations(dot)com
About Health Literacy Innovations
Health Literacy Innovations (HLI) creates tools to help eliminate medical mistakes and confusion due to low health literacy. HLI's flagship product, the Health Literacy Advisor™ (in Spanish--Asesor de Comunicación en Salud™), an add-in to Microsoft Word is an interactive health literacy software tool. As a “health literacy checker," the HLA streamlines the review and simplification process by allowing users to assess the readability of their documents and then fix it using plain language principles. The HLA applies nine well-known readability indices in English and six indices in Spanish and an interactive search-and-replace function to eliminate hard-to-read terms and phrases and medical jargon with plain language alternatives. The combination of these two functions, a document "grade" with a readability score/grade level, and the ReadsEasy™ stamp (a reward for good work) sets the HLA software apart from programs or readability indices alone. For more information, please visit HealthLiteracyInnovations.com or call 301-230-4966.
Aileen Kantor, PRHEALTHCARE, (301) 229-6782, [email protected]
Share this article